Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Asthma, Allergic: early-phase trial registry
1 of 3 indexed Asthma, Allergic trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Asthma, Allergic: 3 US clinical trials tracked, 1 recruiting.
Asthma, Allergic is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Andrew D. Luster, M.D.,Ph.D., running 1 of these trials.
Enrollment posture brief
Registry condition asthma-allergic
OPEN 1 | RECR 33% | LATE 0 | EARLY 2 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Asthma, Allergic lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Asthma, Allergic on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Asthma, Allergic is recruiting below its size-band peers.
1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
Dupilumab Effects Against Aeroallergen Challenge
The University of Texas Health Science Center at San Antonio
NCT05720325
Lung-Resident Memory Th2 Cells in Asthma
Andrew D. Luster, M.D.,Ph.D.
NCT03455959
Study of REGN3500 and Dupilumab in Patients With Asthma
Regeneron Pharmaceuticals
NCT03112577
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Asthma, Allergic records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Asthma, Allergic trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Asthma, Allergic page
3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Asthma, Allergic trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Andrew D. Luster, M.D.,Ph.D. sponsors the most Asthma, Allergic trials on record, review their full trial history before evaluating a specific study. See Andrew D. Luster, M.D.,Ph.D.'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Asthma, Allergic condition card totals 3 registered trials; most-linked intervention Dupilumab; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.